Global Information
회사소개 | 문의 | 비교리스트

수막염 이미징 시장의 기회 분석과 산업 예측(2021-2030년) : 제품 유형(MRI, CT, PET), 질환 유형, 최종사용자별

Meningitis Imaging Market by Product Type (Magnetic Resonance Imaging, Computed Tomography, and Positron Emission Tomography, Disease Type, and End User : Global Opportunity Analysis and Industry Forecast, 2021--2030

리서치사 Allied Market Research
발행일 2021년 12월 상품코드 1059631
페이지 정보 영문 238 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 4,125 ₩ 5,310,000 Excel (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 6,168 ₩ 7,940,000 PDF (Single User License + Covid impact) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 6,929 ₩ 8,919,000 PDF (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,663 ₩ 13,726,000 PDF (Enterprise User License) help
동일 기업 내의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



수막염 이미징 시장의 기회 분석과 산업 예측(2021-2030년) : 제품 유형(MRI, CT, PET), 질환 유형, 최종사용자별 Meningitis Imaging Market by Product Type (Magnetic Resonance Imaging, Computed Tomography, and Positron Emission Tomography, Disease Type, and End User : Global Opportunity Analysis and Industry Forecast, 2021--2030
발행일 : 2021년 12월 페이지 정보 : 영문 238 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 수막염 이미징 시장의 성장은 주로 고령자 인구의 증가와 전인구에서 수막염 환자의 증가에 의해 초래되고 있습니다.

컴퓨터단층촬영(CT) 및 자기 공명(MRI) 영상이 수막염 진단의 지원을 위해 널리 사용되고 있습니다. 또한 신제품 개발을 위한 기술적 진보, 질환의 조기 발견에 대한 환자의 관심 증가, 고령화 사회와 신생아의 증가에 수반하는 다양한 유형의 수막염 질환의 세계 유병률 상승, 저침습 진단에 대한 선호도의 증가, 기타 이미징 양식에 대한 CT, PET, MRI 스캔의 이점 향상도 이 시장의 성장을 촉진할 것으로 예측됩니다.

세계의 수막염 이미징 시장을 조사했으며, 시장의 정의와 개요, 시장 영향요인 분석, 시장 규모의 추이·예측, 유형·질환 유형·최종사용자·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 개요

제3장 시장 구도

  • 시장의 정의·범위
  • 주요 조사 결과
  • Porter의 산업 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
    • 영향 분석
  • COVID-19 : 영향 분석

제4장 수막염 이미징 시장 : 유형별

  • 개요
  • 자기공명영상(MRI)
  • 컴퓨터단층촬영(CT)
  • 양전자방출단층촬영(PET)
    • 주요 시장 동향·성장요인·기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 수막염 이미징 시장 : 질환 유형별

  • 개요
  • 세균성 수막염
  • 시장 규모·예측 : 지역별
  • 바이러스성 수막염
  • 진균성 수막염
  • 기타
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 수막염 이미징 시장 : 최종사용자별

  • 개요
  • 병원·클리닉
  • 진단 센터
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 수막염 이미징 시장 : 지역별

  • 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카·중동·아프리카

제8장 기업 개요 : 수막염 이미징 시장

KSA 22.03.18

LIST OF TABLES

  • TABLE 01.MAGNETIC RESONANCE IMAGING FOR MENINGITIS IMAGING MARKET, BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 02.COMPUTER TOMOGRAPHY FOR MENINGITIS IMAGING MARKET , BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 03.POSITRON EMISSION TOMOGRAPHY MENINGITIS IMAGING MARKET, BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 04.MENINGTIS IMAGING MARKET FOR BACTERIAL MENINGITIS , BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 05.MENIGITIS IMAGING MARKET FOR VIRAL MENINGITIS, BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 06.MENINGTIS IMAGING MARKET FOR FUNGAL MENINGITIS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.MENINGTIS IMAGING MARKET FOR OTHERS, BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 08.HOSPITALS & CLINICS MENINGITIS IMAGING MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.DIAGNOSTIC CENTERS MENINGTIS IMAGING MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.GLOBAL MENINGTIS IMAGING MARKET, BY REGION, 2020-2030 ($THOUSAND)
  • TABLE 11.NORTH AMERICA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 12.NORTH AMERICA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 13.NORTH AMERICA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 14.NORTH AMERICA MENINGITIS IMAGING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 15.U.S. MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 16.U.S. MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 17.U.S. MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 18.CANADA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 19.CANADA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 20.CANADA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 21.MEXICO MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 22.MEXICO MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 23.MEXICO MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 24.EUROPE MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 25.EUROPE MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 26.EUROPE MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 27.EUROPE MENINGITIS IMAGING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 28.GERMANY MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 29.GERMANY MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 30.GERMANY MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 31.FRANCE MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 32.FRANCE MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 33.FRANCE MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 34.UK MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 35.UK MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 36.UK MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 37.ITALY MENINGITIS IMAGING MARKET, BY TYPE, 2020-2030 ($THOUSAND)
  • TABLE 38.ITALY MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 39.ITALY MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 40.SPAIN MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 41.SPAIN MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 42.SPAIN MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 43.REST OF EUROPE MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 44.REST OF EUROPE MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 45.REST OF EUROPE MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 46.ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 47.ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 48.ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 49.ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
  • TABLE 50.JAPAN MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 51.JAPAN MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 52.JAPAN MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 53.CHINA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 54.CHINA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 55.CHINA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 56.AUSTRALIA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 57.AUSTRALIA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 58.AUSTRALIA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 59.INDIA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 60.INDIA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 61.INDIA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 62.SOUTH KOREA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 63.SOUTH KOREA MENINGITIS IMAGING MARKET, BY DISEASE TYPE2020-2030 ($THOUSAND)
  • TABLE 64.SOUTH KOREA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 65.REST OF ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 66.REST OF ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 67.REST OF ASIA-PACIFIC MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 68.LAMEA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 69.LAMEA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 70.LAMEA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 71.LAMEA MENINGITIS IMAGING MARKET, BY COUNTRY, 2020-2030 ($THOUSAND)
  • TABLE 72.LATIN AMERICA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 73.LATIN AMERICA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 74.LATIN AMERICA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 75.MIDDLE EAST AND AFRICA MENINGITIS IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($THOUSAND)
  • TABLE 76.MIDDLE EAST AND AFRICA MENINGITIS IMAGING MARKET, BY DISEASE TYPE, 2020-2030 ($THOUSAND)
  • TABLE 77.SAUDI ARABIA MENINGITIS IMAGING MARKET, BY END USER, 2020-2030 ($THOUSAND)
  • TABLE 78.ACCURAY: COMPANY SNAPSHOT
  • TABLE 79.ACCURAY: PRODUCT PORTFOLIO
  • TABLE 80.CANON: COMPANY SNAPSHOT
  • TABLE 81.CANON: PRODUCT PORTFOLIO
  • TABLE 82.FUJIFILM:COMPANY SNAPSHOT
  • TABLE 83.FUJIFILM: OPERATING SEGMENTS
  • TABLE 84.FUJIFILM: PRODUCT PORTFOLIO
  • TABLE 85.GE:COMPANY SNAPSHOT

GE: OPERATING SEGMENTS

  • TABLE 86.GE: PRODUCT PORTFOLIO
  • TABLE 87.PHILIPS: COMPANY SNAPSHOT
  • TABLE 88.PHILIPS: OPERATING SEGMENTS
  • TABLE 89.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 90.NEUSOFT : COMPANY SNAPSHOT
  • TABLE 91.NEUSOFT: PRODUCT PORTFOLIO
  • TABLE 92.POSITRON: COMPANY SNAPSHOT
  • TABLE 93.POSITRON: PRODUCT PORTFOLIO
  • TABLE 94.SAMSUNG: COMPANY SNAPSHOT
  • TABLE 95.SAMSUNG: PRODUCT PORTFOLIO
  • TABLE 96.SHIMADZU: COMPANY SNAPSHOT
  • TABLE 97.SHIMADZU: OPERATING SEGMENTS
  • TABLE 98.SHIMADZU: PRODUCT PORTFOLIO
  • TABLE 99.SIEMENS: COMPANY SNAPSHOT
  • TABLE 100.SIEMENS : OPERATING SEGMENTS
  • TABLE 101.SIEMENS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.MENINGITIS IMAGING MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE COMPETITIVE RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY, 2020-2030 (%)
  • FIGURE 14.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR COMPUTER TOMOGRAPHY, BY COUNTRY, 2020-2030 (%)
  • FIGURE 15.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2020-2030 (%)
  • FIGURE 16.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR BACTERIAL MENINGITIS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR VIRAL MENINGITIS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR FUNGAL MENINGITIS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF MENINGTIS IMAGING MARKET FOR OTHERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF MENINGITIS IMAGING MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2020-2030 (%)
  • FIGURE 22.ACCURAY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 23.ACCURAY: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 24.CANON: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 25.CANON: REVENUE SHARE BY SEGMENT,2020 (%)
  • FIGURE 26.CANON: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 27.FUJIFILM: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 28.FUJIFILM: REVENUE SHARE BY SEGMENT,2020 (%)
  • FIGURE 29.FUJIFILM: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 30.GE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 31.GE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 32.GE: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 33.PHILIPS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 34.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 35.PHILIPS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 36.SAMSUNG: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 37.SAMSUNG: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 38.SHIMADZU: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 39.SHIMADZU: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 40.SHIMADZU: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 41.SIEMENS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 42.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 43.SIEMENS: REVENUE SHARE BY REGION, 2020 (%)

Meningitis is an infection of the meninges that covers the brain and spinal cord. It is a highly fatal disorder caused by bacterium, Neisseria meningitides. Three membranes that are covered by bacteria include the dura mater, which is a dense outer layer; the arachnoid mater, a thin middle layer; and pia mater, which is a very thin layer that lies directly on the spinal cord and brain. Brain and spinal cord swell due to the bacterial and viral infection around it. The brain injuries, cancer, and infectious diseases are reasons to cause meningitis. It can lead to life-threatening blood poisoning and leads to damage of brain and nerves. There are several types of meningitis such as bacterial meningitis, viral meningitis, and fungal meningitis.

Bacterial meningitis spread via certain foods like unpasteurized dairy and deli meats, this factors cause meningitis. In addition, the Center for Disease Control states that bacterial meningitis spreads from person to person. It can affect anyone, but it is most common in babies, young children, and young adults. Bacterial meningitis is more severe and may lead to long-term complications and is most common in infants under the age of 1 year and in adults with the age of 16-21. The most common symptoms of bacterial meningitis are rashes on skin, painful stiff neck, and seizures.

There are several diagnostic imaging procedures, which show images of brain and detect the infection. CT scanning is frequently the most effective approach for diagnosing meningitis. It is a painless, noninvasive process and can disclose internal injuries and bleeding early enough in an emergency situation to help save lives. It is a method used in radiology to provide comprehensive pictures of the body for diagnostic reasons. Cross-sectional images produced by a CT scan can be reformatted in several planes and even three-dimensional (3D) images can be produced that can be seen on a computer display, printed on film, or transmitted to electronic devices Moreover, magnetic resonance imaging (MRI) may show inflammatory changes in meninges. This imaging procedures gives more information about meningitis infection.

Growth of the global meningitis imaging market is majorly driven by rising geriatric population and increasing meningitis cases in the overall population. Computed tomography (CT) and magnetic resonance (MRI) imaging are widely used to aid in diagnosis of meningitis. About 3,000 people in the United States are diagnosed with bacterial meningitis each year and according to the Harvard Medical School in 2021, more than 80 million CT scans are performed in the U.S. each year, compared to just 3 million in 1980.

Increase in prevalence of meningitis is one of the major reasons that boost the need for meningitis imaging scans. According to the World Health Organization (WHO), meningitis caused an estimated 2,50,000 deaths in 2019. World Health Organization with its global partners involved in meningitis prevention and control which led the development of strategies to defeat meningitis by 2030. In addition, Neisseria meningitis is found worldwide, but the rise in occurrence of "meningitis belt" of sub-saharan Africa results in propels the market growth. Moreover, in 2020, Hyperfine Research received the US FDA approval for portable MRI technology, the Swoop device. Thus, rise in development of imaging systems to determine efficacy of treatment of meningitis is anticipated to drive growth of the meningitis imaging market.

In addition, technological advancements for development of new products, growing patient emphasis for early detection of diseases, rise in global prevalence of various types of meningitis disease, coupled with an aging population and newborns, increase in preference for minimally invasive diagnostic procedures, and rise in benefits of CT, PET, and MRI scans over other imaging modalities are anticipated to drive growth of the meningitis imaging market.

On the contrary, high cost of installation of diagnostic imaging instruments and their maintenance, lack of reimbursement in some countries, and radiation from imaging procedure can lead to adverse side effects these factors are expected to hinder the growth of the meningitis imaging market.

Emerging markets and significant R&Ds to develop efficient imaging instruments, innovation of various systems and unmet demand in the under developed and developing countries is projected to provide substantial growth opportunities for key players in the meningitis imaging market.

The global meningitis imaging market is segmented onto the basis of product type, disease type, end user, and region. On the basis of product type, the market is categorized into, magnetic resonance Imaging (MRI), computed tomography (CT), and positron emission tomography (PET). By disease type, it is fragmented into bacterial meningitis, viral meningitis, fungal meningitis, and others. By end user, it is categorized into hospitals & clinics and diagnostic centres. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global meningitis imaging market are Accuray Incorporated, Canon Medical Systems Corporation, Fujifim Holdings Corporation, GE Healthcare, Koninklijke Philips N.V, Neusoft Medical Systems, Positron Corporation, Samsung Electronics Co.Ltd., Shimadzu Corporation, and Siemens AG.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global meningitis imaging market to identify the prevailing opportunities.
  • This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Region- & country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Product Type

  • Magnetic Resonance Imaging (MRI)
  • Computer Tomography (CT)
  • Positron Emission Tomography (PET)

By Disease Type

  • Bacterial Meningitis
  • Viral Meningitis
  • Fungal Meningitis
  • Others

By End User

  • Hospitals & Clincs
  • Diagnostic Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East & Africa

KEY MARKET PLAYERS

  • Accuray Incorporated
  • Canon Medical Systems Corporation
  • Fujifim Holdings Corporation
  • GE Healthcare
  • Koninklijke Philips N.V
  • Neusoft Medical Systems
  • Positron Corporation
  • Samsung Electronics Co. Ltd.
  • Shimadzu Corporation
  • Siemens AG

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description

Key benefits for stakeholders

  • 1.2.Key market segments
    • 1.2.1.List of key players profile in the report
  • 1.3.Research methodology
    • 1.3.1.Secondary research
    • 1.3.2.Primary research
    • 1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Escalating demand for healthcare services from an aging population
      • 3.5.1.2.Rise in prevalence of meningitis disease
      • 3.5.1.3.Greater consumer awareness and demand for preventive diagnostic screening
      • 3.5.1.4.Utilization of artificial intelligence and augmented reality
      • 3.5.1.5.Technological advancements in meningitis imaging systems
    • 3.5.2.Restraint
      • 3.5.2.1.High cost of installation and maintenance
      • 3.5.2.2.Lack of adequate reimbursement and stringent regulatory framework
    • 3.5.3.Opportunity
      • 3.5.3.1.Growth opportunities in emerging markets
    • 3.5.4.Impact analysis
  • 3.6.Impact analysis of COVID-19 on the meningitis imaging market

CHAPTER 4:MENINGITIS IMAGING MARKET, BY TYPE

  • 4.1.Overview
  • 4.2.Magnetic Resonance Imaging (MRI)
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Computed Tomography (CT)
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Positron Emission Tomography (PET)
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country

CHAPTER 5:MENINGTIS IMAGING MARKET, BY DISEASE TYPE

  • 5.1.Overview
  • 5.2.Bacterial Meningitis
  • 5.2.1 Market size and forecast, by region
    • 5.2.1.Market analysis, by country
  • 5.3.Viral Meningitis
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Fungal Meningitis
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Others
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country

CHAPTER 6:MENINGTIS IMAGING MARKET, BY END USER

  • 6.1.Overview
  • 6.2.Hospitals & Clinics
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Diagnostic Centers
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country

CHAPTER 7:MENINGITIS IMAGING MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.North America meningitis imaging market, by product type
    • 7.2.3.North America meningitis imaging market, by disease type
    • 7.2.4.North America meningitis imaging market, by end user
    • 7.2.5.Market size and forecast, by country
      • 7.2.5.1.U.S.
      • 7.2.5.1.1.U.S. meningitis imaging market, by product type
      • 7.2.5.1.2.U.S. meningitis imaging market, by disease type
      • 7.2.5.1.3.U.S. meningitis imaging market, by end User
      • 7.2.5.2.Canada
      • 7.2.5.2.1.Canada meningitis imaging market, by product type
      • 7.2.5.2.2.Canada meningitis imaging market, by disease type
      • 7.2.5.2.3.Canada meningitis imaging market, by end user
      • 7.2.5.3.Mexico
      • 7.2.5.3.1.Mexico meningitis imaging market, by product type
      • 7.2.5.3.2.Mexico meningitis imaging market, by disease type
      • 7.2.5.3.3.Mexico meningitis imaging market, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Europe meningitis imaging market, by product type
    • 7.3.3.Europe meningitis imaging market, by disease type
    • 7.3.4.Europe meningitis imaging market, by end user
    • 7.3.5.Market size and forecast, by country
      • 7.3.5.1.Germany
      • 7.3.5.1.1.Germany meningitis imaging market, by product type
      • 7.3.5.1.2.Germany meningitis imaging market, by disease type
      • 7.3.5.1.3.Germany meningitis imaging market, by end user
      • 7.3.5.2.France
      • 7.3.5.2.1.France meningitis imaging market, by product type
      • 7.3.5.2.2.France meningitis imaging market, by disease type
      • 7.3.5.2.3.France meningitis imaging market, by end user
      • 7.3.5.3.UK
      • 7.3.5.3.1.UK meningitis imaging market, by product type
      • 7.3.5.3.2.UK meningitis imaging market, by disease type
      • 7.3.5.3.3.UK meningitis imaging market, by end user
      • 7.3.5.4.Italy
      • 7.3.5.4.1.Italy meningitis imaging market, by product type
      • 7.3.5.4.2.Italy meningitis imaging market, by disease type
      • 7.3.5.4.3.Italy meningitis imaging market, by end user
      • 7.3.5.5.Spain
      • 7.3.5.5.1.Spain meningitis imaging market, by product type
      • 7.3.5.5.2.Spain meningitis imaging market, by disease type
      • 7.3.5.5.3.Spain meningitis imaging market, by end user
      • 7.3.5.6.Rest of Europe
      • 7.3.5.6.1.Rest of Europe meningitis imaging market, by product type
      • 7.3.5.6.2.Rest of Europe meningitis imaging market, by disease type
      • 7.3.5.6.3.Rest of Europe meningitis imaging market, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Asia-Pacific meningitis imaging market, by product type
    • 7.4.3.Asia-Pacific meningitis imaging market, by disease type
    • 7.4.4.Asia-Pacific meningitis imaging market, by end user
    • 7.4.5.Market size and forecast, by country
      • 7.4.5.1.Japan
      • 7.4.5.1.1.Japan meningitis imaging market, by product type
      • 7.4.5.1.2.Japan meningitis imaging market, by disease type
      • 7.4.5.1.3.Japan meningitis imaging market, by end user
      • 7.4.5.2.China
      • 7.4.5.2.1.China meningitis imaging market, by product type
      • 7.4.5.2.2.China meningitis imaging market, by disease type
      • 7.4.5.2.3.China meningitis imaging market, by end user
      • 7.4.5.3.Australia
      • 7.4.5.3.1.Australia meningitis imaging market, by product type
      • 7.4.5.3.2.Australia meningitis imaging market, by disease type
      • 7.4.5.3.3.Australia meningitis imaging market, by end user
      • 7.4.5.4.India
      • 7.4.5.4.1.India meningitis imaging market, by product type
      • 7.4.5.4.2.India meningitis imaging market, by disease type
      • 7.4.5.4.3.India meningitis imaging market, by end user
      • 7.4.5.5.South Korea
      • 7.4.5.5.1.South Korea meningitis imaging market, by product type
      • 7.4.5.5.2.South Korea meningitis imaging market, by disease type
      • 7.4.5.5.3.South Korea meningitis imaging market, by end user
      • 7.4.5.6.Rest of Asia-Pacific
      • 7.4.5.6.1.Rest of Asia-Pacific meningitis imaging market, by product type
      • 7.4.5.6.2.Rest of Asia-Pacific meningitis imaging market, by disease type
      • 7.4.5.6.3.Rest of Asia-Pacific meningitis imaging market, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.LAMEA meningitis imaging market, by product type
    • 7.5.3.LAMEA meningitis imaging market, by disease type
    • 7.5.4.LAMEA meningitis imaging market, by end user
    • 7.5.5.Market size and forecast, by country
      • 7.5.5.1.Latin America
      • 7.5.5.1.1.Latin America meningitis imaging market, by product type
      • 7.5.5.1.2.Latin America meningitis imaging market, by disease type
      • 7.5.5.1.3.Latin America meningitis imaging market, by end user
      • 7.5.5.2.Middle East & Africa
      • 7.5.5.2.1.Middle East and Africa meningitis imaging market, by product type
      • 7.5.5.2.2.Middle East and Africa meningitis imaging market, by disease type
      • 7.5.5.2.3.Middle East and Africa meningitis imaging market, by end user

CHAPTER 8:COMPANY PROFILES: MENINGITIS IMAGING MARKET

1.1ACCURAY INCORPORATED

1.2CANON MEDICAL SYSTEMS CORPORATION (CANON INC.)

    • 8.1.1.

1.3FUJIFILM HOLDING CORPORATION

1.4GE HEALTHCARE

1.5KONINKLIJKE PHILIPS NV

  • 1.4.6 Business performance

1.6NEUSOFT MEDICAL SYSTEMS CO. LTD.

      • 8.1.2.1.6.4 Key strategic moves and developments

1.7POSITRON CORPORATION

      • 8.1.3.1.7.1 Company overview
      • 8.1.4.1.7.2 Company snapshot
    • 8.1.5.
      • 8.1.6.1.7.3 0perating business segments
      • 8.1.7.1.7.4 Product portfolio
    • 8.1.8.
    • 8.1.9.
    • 8.1.10.

1.8SAMSUNG ELECTRONICS CO.LTD

      • 8.1.11.1.8.1 Company overview
      • 8.1.12.1.8.2 Company snapshot
    • 8.1.13.
      • 8.1.14.1.8.3 Operating business segments
      • 8.1.15.1.8.4 Product portfolio
      • 8.1.16.1.8.5 Business performance

1.9SHIMADZU CORPORATION

  • 1.9.1 Company overview
  • 1.9.2 Company snapshot
  • 1.9.3 Operating business segments

1.10SEIMENS AG

Back to Top
전화 문의
F A Q